Real-world evaluation of effectiveness, persistence and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

First published 17/05/2021

Last updated 02/07/2024

EU PAS number:

EUPAS39635

Study

Finalised

Documents

Study protocol

Initial protocol

A3921398 Final Non-Interventional Protocol Study Abstract

English (1.24 MB - PDF)View document

Updated protocol

A3921398 Non-Interventional Study Protocol 04 March 2021

First published: 22/02/2024

English (1.87 MB - PDF)View document

Study results

Study report

A3921398 Non Interventional Study Report 19 July 2022_Redacted

English (6.43 MB - PDF)View document

A3921398 Non Interventional Study Report Abstract 19 July 2022_Redacted

English (1.93 MB - PDF)View document

Other information

Study, other information

A3921398 Non Interventional Study Report Abstract 19 July 2022_Redacted.pdf

English (1.93 MB - PDF)View document

ENCePP Seal

ENCePP Seal documents

Secondary tabs